International circumpolar surveillance system for invasive pneumococcal disease, 1999-2005

Emerging Infectious Diseases

Volumn 14, Issue 1, 2008, Pages 25-33

  Bruce, Michael G ^a,r   Deeks, Shelley L ^b,l   Zulz, Tammy ^a   Bruden, Dana ^a   Navarro, Christine ^b   Lovgren, Marguerite ^c   Jette, Louise ^d   Kristinsson, Karl ^e   Sigmundsdottir, Gudrun ^e   Jensen, Knud Brinkløv ^f   Lovoll, Oistein ^g   Nuorti, J Pekka ^h   Herva, Elja ^h   Nystedt, Anders ⁱ   Sjostedt, Anders ^j   Koch, Anders ^k   Hennessy, Thomas W ^a   Parkinson, Alan J ^a   Proulx, Jean François ^m   Carlin, Robert ⁿ   Corriveau, Andre ^o   Case, Cheryl ^o   Larke, Bryce ^p   Hemsley, Colleen ^p   Sobel, Isaac ^q   Palacios, Carolina ^q   Tyrell, Gregory ^c   Reasonover, Alisa ^a   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c National Centre for Streptococcus   (Canada)

^d Quebec Public Health Laboratory   (Canada)

^e LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^f Institution of the Chief Medical Officer   (Greenland)

^g NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^h NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

ⁱ SUNDERBY HOSPITAL   (Sweden)

^j UMEÅ UNIVERSITY   (Sweden)

^k STATENS SERUM INSTITUT   (Denmark)

^l NATIONAL CENTRE FOR IMMUNISATION RESEARCH AND SURVEILLANCE   (Australia)

^m Nunavik Regional Board of Health and Social Services   (Canada)

ⁿ Cree Board of Health and Social Services of James Bay   (Canada)

^o DEPARTMENT OF ENVIRONMENT AND NATURAL RESOURCES   (Canada)

^p Yukon Health and Social Services   (Canada)

^q Nunavut Department of Health   (Canada)

^r NATIONAL CENTER FOR PREPAREDNESS DETECTION AND CONTROL OF INFECTIOUS DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARCTIC; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; CANADA; CHILD; FEMALE; FINLAND; GREENLAND; HUMAN; ICELAND; INCIDENCE; INFANT; MALE; NONHUMAN; NORWAY; PNEUMONIA; RISK FACTOR; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SWEDEN; UNITED STATES;

EID: 38049047018     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1401.071315     Document Type: Article

References (30)

1. Parkinson AJ, Bell AA, Butler JC. International circumpolar surveillance of infectious diseases: monitoring community health in the Arctic. Int J Circumpolar Health. 1999;58:222-5.
2. Christiansen J, Poulsen P, Ladefoged K. Invasive pneumococcal disease in Greenland. Scand J Infect Dis. 2004;36:325-9.
3. Vaudry W, Talling D. Invasive pneumococcal infection in First Nations children in northern Alberta. Can Commun Dis Rep. 2002;28:165-72.
4. Scheifele D, Law B, Vaudry W, Halperin S, Kellner J, King A, et al. Invasive pneumococcal infections among Canadian aboriginal children. Can Commun Dis Rep. 2003;29:37-42.
5. Davidson M, Parkinson AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks DJ. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990 - ethnic differences and opportunities for prevention. J Infect Dis. 1994;170:368-76.
6. Scheifele D, Halperin S, Pelletier L, Talbot J. Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT). Clin Infect Dis. 2000;31:58-64.
7. Zulz T, Reasonover A, Lovgren M, Jette L, Kaltoft MS, Bruce MG, et al. International Circumpolar Surveillance interlaboratory quality control programme, 1999-2004 [abstract]. Clin Microbiol Infect. 2007;13(Suppl 1):176.
8. Proulx JF, Dery S, Jette LP, Ismael J, Libman M, De Wals P. Pneumonia epidemic caused by a virulent strain of Streptococcus pneumoniae serotype 1 in Nunavik, Quebec. Can Commun Dis Rep. 2002;28:129-31.
9. Macey JF, Roberts A, Lior L, Tam TW, VanCaeseele P. Outbreak of community-acquired pneumonia in Nunavut, October and November, 2000. Can Commun Dis Rep. 2002;28:131-8.
10. Ndiaye AA, de Wals P, Proulx JF, Ouakki M, Jette L, Dery S. Impact of a mass immunization campaign to control an outbreak of severe respiratory infections in Nunavik, northern Canada. Int J Circumpolar Health. 2006;65:297-304.
11. Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA. 2005;294:2043-51.
12. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997;337:970-6.
13. Dahl MS, Trollfors B, Claesson BA, Brandberg LL, Rosengren A. Invasive pneumococcal infections in Southwestern Sweden: a second follow-up period of 15 years. Scand J Infect Dis. 2001;33:667-72.
14. Flannery B, Schrag S, Bennett NM, Lynfield R, Harrison LH, Reingold A, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA. 2004;291:2197-203.
15. Hennessy TW, Singleton RJ, Bulkow LR, Bruden DL, Hurlburt DA, Parks D, et al. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. Vaccine. 2005;23:5464-73.
16. Levine OS, O'Brien KL, Knoll M, Adegbola RA, Black S, Cherian T, et al. Pneumococcal vaccination in developing countries. Lancet. 2006;367:1880-2.
17. Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA. 2006;295:1668-74.
18. Whitney CG. Impact of conjugate pneumococcal vaccines. Pediatr Infect Dis J. 2005;24:729-30.
19. Butler JC, Parkinson AJ, Funk E, Beller M, Hayes G, Hughes JM. Emerging infectious diseases in Alaska and the Arctic: a review and a strategy for the 21st century. Alaska Med. 1999;41:35-43.
20. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297:1784-92.
21. Koch A, Bruce M, Homoe P. Infectious diseases. In: Young TK, Bjerregaard P, editors. Health transitions in Arctic populations. Toronto: University of Toronto Press. In press.
22. Roche PW, Krause VL, Bartlett M, Coleman D, Cook H, Davis C, et al. Invasive pneumococcal disease in Australia, 2004. Commun Dis Intell. 2006;30:80-92.
23. Cortese MM, Wolff M, Almeido-Hill J, Reid R, Ketcham J, Santosham M. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch Intern Med. 1992;152:2277-82.
24. O'Brien KL, Shaw J, Weatherholtz R, Reid R, Watt J, Croll J, et al. Epidemiology of invasive Streptococcus pneumoniae among Navajo children in the era before use of conjugate pneumococcal vaccines, 1989-1996. Am J Epidemiol. 2004;160:270-8.
25. Voss L, Lennon D, Okesene-Gafa K, Ameratunga S, Martin D. Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand. Pediatr Infect Dis J. 1994;13:873-8.
26. Fraser D, Givon-Lavi N, Bilenko N, Dagan R. A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice. Clin Infect Dis. 2001;33:421-7.
27. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-46.
28. Rudolph KM, Parkinson AJ, Reasonover AL, Bulkow LR, Parks DJ, Butler JC. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991-1998. J Infect Dis. 2000;182:490-6.
29. Karchmer AW. Increased antibiotic resistance in respiratory tract pathogens: PROTEKT US - an update. Clin Infect Dis. 2004;39(Suppl 3):S142-50.
30. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917-24.